Q2 2019 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to Aurinia Pharmaceuticals Inc. Second Quarter 2019 Conference Call. (Operator Instructions). Please note, this conference is being recorded.
I would now like to introduce you to today's host, Dr. Glenn Schulman. Thank you. You may begin.
Thanks, Kevin, and good afternoon, everyone. Welcome to Aurinia's Second Quarter 2019 Results Conference Call. Joining me on today's call from the Aurinia team are Mr. Peter Greenleaf, President and CEO; Dennis Bourgeault, our CFO; Dr. Neil Solomons, Chief Medical Officer; Michael Martin, Chief Operating Officer of Aurinia; and Dr. Simrat, our Head of Medical Affairs. This afternoon, we issued our press release detailing our second quarter 2019 financial results. The press release and associated financial statement package is available on our website at www.auriniapharma.com and a 6-K was filed as well with the SEC.
I'd like to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |